Hutch News

Hutch News

Stories tagged 'Marie Bleakley'

3 big new leukemia research projects advance cutting-edge cell therapies, stem cell transplant

$20M renewal of 4-decade-long federal grant to Hutch scientists

May 31, 2018 | By Susan Keown / Fred Hutch News Service

The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.

View story >


What’s new in combatting chronic graft-vs.-host disease

Decades after the development of bone marrow transplant, researchers are making headway against one of its most common and deadly side effects

April 2, 2018 | By Rachel Tompa / Fred Hutch News Service

Up to 40% of transplant recipients develop chronic graft-vs.-host disease, which can last for years. But chronic GVHD is treatable, and new therapies and preventive measures are arriving and being tested in trials.

View story >


An opening night for heroes

Cancer survivor Rose Ibarra to be honored by Fred Hutch and Mariners at Safeco Field

March 29, 2018 | By Sabin Russell / Fred Hutch News Service

A two-time survivor of acute lymphoblastic leukemia, Rose Ibarra of West Seattle is the first of nine “Hutch Heroes” to be honored by the Mariners and Fred Hutch during Thursday home games this season.

View story >


Science without borders

At Fred Hutch and other U.S. research centers, a global village works to cure cancer and other diseases

Oct. 16, 2017 | By Mary Engel / Fred Hutch Research Center

Fred Hutch, like other major U.S. cancer research centers, attracts top scientists from around the world working to cure cancer, HIV and other diseases

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 6, 2017

Dr. Marie Bleakley receives innovator award for new leukemia immunotherapies; Dr. Anthony Rongvaux receives grant from Lupus Research Alliance; Drs. Benjamin Greer, Wui-Jin Koh win NCCN award.

View story >


'Back to normal life'

Sorting stem cells before transplant helps lower the risk of graft-vs.-host disease, researcher reports

Dec. 5, 2016 | By Bill Briggs / Fred Hutch News Service

Patients in a clinical trial, including Dr. Curtis Mack, had lower rates of graft-vs.-host disease when researchers filtered stem cells before transplant, scientists reported Monday.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.